The National Institutes of Health just cut an $11.2 million check to the Arkansas Integrative Metabolic Research Center at the University of Arkansas, Fayetteville — and not a single working American who funded it will ever see a return on that investment.

This is Phase 2 money, stacked on top of the $10.8 million Phase 1 grant that created the center in 2021. That's $22 million in direct NIH funding alone. The center's director, Narasimhan Rajaram, told Arkansas Online he now aims to pull in $75 million to $80 million in external research funding over the next five years. The center already claims $52.5 million in external funding generated by its 61 faculty across eight departments and five colleges. This is not a research operation. This is a grant-harvesting operation — and the crop is your tax money.

The university's own release says the center studies "the role of cell and tissue metabolism in disease, human development and repair processes," with possible implications for cancer, diabetes, and obesity. Possible. Implications. Meanwhile, fentanyl kills over 70,000 Americans a year. Communities across this country are hollowing out. And NIH is writing eight-figure checks for faculty mentoring programs and "bioenergetics core facilities" so early-career academics can "graduate" to their next federal grant.

The center's own description reveals the game: early-stage faculty get startup funding, then compete for "Research Project Leader" designation, which comes with three years of funding and mentoring to help them — wait for it — apply for more NIH and National Science Foundation grants. The system feeds itself. The purpose of a grant is to get the next grant.

The IDeA program that funds this center exists, by NIH's own admission, to "build research capacity" in states that historically received low NIH funding. Translation: spread the money around so more congressional districts have a stake in the NIH budget. Arkansas Online notes Arkansas is one of 24 IDeA-eligible states — that's nearly half the country now designated as a recipient class for biomedical pork.

Then there's the other side of the NIH portfolio. The Guardian reports the Trump administration just canceled roughly $15 million in grants at Emory University and the University of Pittsburgh that were studying how "discrimination" and "structural racism" affect long-term brain health. Researchers there admit they can't even measure structural racism — they just use it as "framing." One researcher, Andrea Rosso, said: "We can't come up with an intervention that's going to stop structural racism – wish we could." So the public paid millions for a study the lead researcher concedes cannot produce an intervention. The Supreme Court already allowed the administration to cancel $783 million in NIH funding in a 5-4 shadow docket ruling after a lower court found the cancellations illegal.

Here's the honest picture: NIH runs a $47 billion portfolio that functions as a jobs program for the academic class. Some of it lands on real disease research. Some of it lands on "structural racism framing" that produces nothing. Almost none of it is accountable to the people who pay for it. The Arkansas center may study metabolism — but it was built to chase grants, not cure disease, and the director's own words confirm it.

The question isn't whether metabolism research has value. The question is why Washington keeps writing blank checks to universities while the country they're supposed to serve falls apart.